Literature DB >> 7697729

Heligmosomoides polygyrus adult worm homogenate superantigen: presentation to T cells requires MHC class I positive accessory cells.

M Robinson1, T R Gustad, N Storey, C S David.   

Abstract

A series of experiments were carried out to further characterize the previously discovered Heligmosomoides polygyrus, adult worm homogenate (AWH), superantigen. AWH, in contrast to staphylococcal enterotoxin B (SEB) superantigen, was totally unable to stimulate naive thymocytes, in either the presence or the absence of exogenous accessory cells (AC). Experiments using AC from B10 congenic mice failed to indicate a requirement for a specific MHC haplotype for successful presentation of the AWH superantigen and also indicated that the presence or absence of the H-2,E molecule on AC did not affect AWH stimulation of T cell hybridomas. Furthermore, AWH was found to require the presence of MHC class I-positive AC in order to stimulate T cell hybridomas, while, in contrast, the absence of MHC Class II on AC did not affect the superantigenic properties of AWH. Initial characterization of the T cell hybridomas stimulated by the AWH superantigen, indicated that all were CD4-positive and that three of them expressed TCR V beta 8.1. Hence AWH superantigen can stimulate TCR V beta 8.1/CD4-positive T cells only in the presence of MHC Class I-positive AC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697729     DOI: 10.1006/cimm.1995.1026

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Extract of Nippostrongylus brasiliensis stimulates polyclonal type-2 immunoglobulin response by inducing De novo class switch.

Authors:  H N Ehigiator; A W Stadnyk; T D Lee
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Protective immunity against the gastrointestinal nematode Nippostrongylus brasiliensis requires a broad T-cell receptor repertoire.

Authors:  Alexander Seidl; Marc Panzer; David Voehringer
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.